Molecular Oncology

Papers
(The H4-Index of Molecular Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information174
100
PoDCall: a robust tool for automated droplet classification in DNA‐methylation droplet digital PCR98
64
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”57
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with 46
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”41
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma39
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer38
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy38
Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity38
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection36
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system35
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer35
Issue Information34
Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2 + mononuc34
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity34
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy34
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer33
Unraveling LINE ‐1 retrotransposition in head and neck squamous cell carcinoma33
Exosomes secreted by ST3GAL5high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment30
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer30
An arms‐race against resistance: leukemic stem cells and lineage plasticity29
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities28
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1 28
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐ CD 73/anti‐ 28
Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread26
The multispecies microbial cluster of Fusobacterium , Parvimonas , Bacteroides 26
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo26
0.069921970367432